Published: 20 March 2019
Author(s): J.M. Figueira Gonçalves, M.A. García Bello, N. Bethencourt Martín, D. Díaz Pérez, Lina Inmaculada Pérez-Méndez
Section: Letter to the Editor
Immunocompromised patients with certain underlying diseases, such as chronic obstructive pulmonary disease (COPD) or cardiovascular disease (CVD), are more susceptible to Streptococcus pneumoniae (pneumococcus) infection, characterised by a poor clinical course and severe disease pattern [1,2].